HK1204574A1 - Multivalent meningococcal derivatized polysaccharide protein conjugates and corresponding vaccines - Google Patents

Multivalent meningococcal derivatized polysaccharide protein conjugates and corresponding vaccines

Info

Publication number
HK1204574A1
HK1204574A1 HK15105208.0A HK15105208A HK1204574A1 HK 1204574 A1 HK1204574 A1 HK 1204574A1 HK 15105208 A HK15105208 A HK 15105208A HK 1204574 A1 HK1204574 A1 HK 1204574A1
Authority
HK
Hong Kong
Prior art keywords
protein conjugates
polysaccharide protein
derivatized polysaccharide
multivalent meningococcal
corresponding vaccines
Prior art date
Application number
HK15105208.0A
Other languages
English (en)
Chinese (zh)
Inventor
Robert P Ryall
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of HK1204574A1 publication Critical patent/HK1204574A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
HK15105208.0A 2003-05-07 2015-06-01 Multivalent meningococcal derivatized polysaccharide protein conjugates and corresponding vaccines HK1204574A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46858103P 2003-05-07 2003-05-07

Publications (1)

Publication Number Publication Date
HK1204574A1 true HK1204574A1 (en) 2015-11-27

Family

ID=33476662

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105208.0A HK1204574A1 (en) 2003-05-07 2015-06-01 Multivalent meningococcal derivatized polysaccharide protein conjugates and corresponding vaccines

Country Status (9)

Country Link
US (1) US20050002957A1 (ja)
EP (2) EP2386313A1 (ja)
JP (3) JP2006528936A (ja)
CN (2) CN104225587B (ja)
AU (2) AU2004240558A1 (ja)
BR (1) BRPI0410341B8 (ja)
CA (1) CA2524860C (ja)
HK (1) HK1204574A1 (ja)
WO (1) WO2004103400A2 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
EP2191844B1 (en) 2003-01-30 2014-03-05 Novartis AG Injectable vaccines against multiple meningococcal serogroups
GB0406013D0 (en) * 2004-03-17 2004-04-21 Chiron Srl Analysis of saccharide vaccines without interference
EP2272531A3 (en) 2004-04-30 2011-04-13 Novartis Vaccines and Diagnostics S.r.l. Integration of meningococcal conjugate vaccination
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
EP2351582A1 (en) * 2004-08-30 2011-08-03 Sanofi Pasteur, Inc. Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
CA2580693A1 (en) * 2004-09-21 2006-03-30 Sanofi Pasteur, Inc. Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
US9931397B2 (en) * 2005-06-27 2018-04-03 Glaxosmithkline Biologicals S.A. Immunogenic composition
GB0513071D0 (en) * 2005-06-27 2005-08-03 Glaxosmithkline Biolog Sa Immunogenic composition
US7955817B2 (en) 2005-09-02 2011-06-07 Glaxosmithkline Biologicals S.A. Vaccine protection assay
DE602005024320D1 (de) 2005-09-05 2010-12-02 Glaxosmithkline Biolog Sa Bakterizidie-serumtest für n. meningitidis spezifische antiseren
KR101838938B1 (ko) * 2006-03-17 2018-03-15 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 복합 다가 면역원성 콘쥬게이트의 제조 방법
PT2004225E (pt) 2006-03-22 2012-05-30 Novartis Ag Regimes para imunização com conjugados meningocócicos
US10828361B2 (en) * 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
EP2007427A4 (en) 2006-04-11 2012-04-04 Yeda Res & Dev IMPROVED VACCINES COMPRISING PEPTIDE MULTIPLE MEDIA DERIVED FROM HSP60
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
CN101428144A (zh) * 2008-12-19 2009-05-13 长春长生生物科技股份有限公司 流脑多糖联合疫苗及制备工艺
CN102858370A (zh) * 2010-05-03 2013-01-02 Dcb-美国有限责任公司 用作疫苗的多糖与去毒大肠杆菌(e.coli)不耐热肠毒素(lt)的偶联
CN103623401A (zh) * 2012-08-23 2014-03-12 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
CN102861326A (zh) * 2012-09-19 2013-01-09 天津康希诺生物技术有限公司 流脑多糖-蛋白质缀合疫苗及制备方法
CN104829711B (zh) * 2014-04-08 2018-04-03 北京天成新脉生物技术有限公司 脑膜炎球菌荚膜多糖单克隆抗体及其应用
MX2019002489A (es) 2016-09-02 2019-10-21 Sanofi Pasteur Inc Vacuna contra neisseria meningitidis.
CN108743936B (zh) * 2018-06-14 2022-03-15 中国科学院过程工程研究所 一种细菌多糖结合疫苗及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5422427A (en) 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US5445817A (en) 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US5965714A (en) * 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
AU2002309706A1 (en) * 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine

Also Published As

Publication number Publication date
BRPI0410341B1 (pt) 2019-07-16
CN104225587B (zh) 2017-07-21
WO2004103400A2 (en) 2004-12-02
US20050002957A1 (en) 2005-01-06
BRPI0410341B8 (pt) 2021-05-25
EP1624888B1 (en) 2016-10-12
JP2006528936A (ja) 2006-12-28
CA2524860A1 (en) 2004-12-02
JP2014193929A (ja) 2014-10-09
JP2011042693A (ja) 2011-03-03
BRPI0410341A (pt) 2006-05-30
EP1624888A2 (en) 2006-02-15
CN1852733A (zh) 2006-10-25
AU2004240558A1 (en) 2004-12-02
EP2386313A1 (en) 2011-11-16
CN104225587A (zh) 2014-12-24
CA2524860C (en) 2016-09-13
WO2004103400A3 (en) 2005-03-24
AU2010257242A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
HK1204574A1 (en) Multivalent meningococcal derivatized polysaccharide protein conjugates and corresponding vaccines
IL184154A0 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
HK1195512A1 (zh) 多糖-蛋白軛合物疫苗
AU2003257003A8 (en) Chimeric multivalent polysaccharide conjugate vaccines
HUS1600040I1 (hu) Multivalens, meningokokkusz-eredetû poliszaccharid és fehérje konjugátumát tartalmazó vakcina
HK1213184A1 (zh) 多價肺炎球菌多糖-蛋白質綴合物組合物
GB0321615D0 (en) Improvements in vaccination
IL181951A0 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
HK1120230A1 (en) Pneumococcal polysaccharide conjugate vaccine
EP1613274A4 (en) CONJUGATES COMPRISING THE HUMAN INTERLEUKINE 18 THERE AND 18 MUTANTS OF THESE CONJUGATES BY SUBSTITUTION
IL172094A0 (en) Polymeric conjugates and methods for the preparation thereof
HK1215189A1 (zh) 多價肺炎球菌多糖-蛋白綴合物組合物
EP1819226A4 (en) COMBINATIONS AND METHODS OF IMMUNOSTIMULATION
EP1804831A4 (en) VACCINES BASED ON LLO AND LISTERIA
ZA200609500B (en) Adjuvanted Shiga toxin B-subunit based vaccines
EP1781689A4 (en) CONJUGATES AND THEIR THERAPEUTIC APPLICATIONS
AU2003276884A8 (en) Multivalent constructs for therapeutic and diagnostic applications
AU2003245252A8 (en) Enhanced sulfated polysaccharide formulations, methods and preparations and their uses thereof
IL174479A0 (en) Hemiasterlin derivatives and uses thereof
ZA200701675B (en) Multivalent meningococcal derivatized polysaccharideprotein conjugates and vaccine
GB0206461D0 (en) Improvements in vaccination
EP1450752A4 (en) MULTIVALENT VACCINE COMPOSITIONS CONTAINING STREPTOCOCCUS AND METHODS OF USE
EP1814393A4 (en) TOLEROGENIC VACCINE AND METHOD THEREOF
EP1963522A4 (en) MULTIVALENT MENINGOCOCCAL DERIVATIVE POLYSACCHARIDE-PROTEIN CONJUGATES AND VACCINE
PL374358A1 (en) Immunogenic conjugates

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240502